IRIS
ALONCI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.841
EU - Europa 2.470
AS - Asia 1.973
SA - Sud America 872
AF - Africa 52
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.758
SG - Singapore 919
BR - Brasile 774
IE - Irlanda 622
SE - Svezia 593
CN - Cina 527
HK - Hong Kong 270
DE - Germania 250
UA - Ucraina 231
IT - Italia 213
FI - Finlandia 137
GB - Regno Unito 134
RU - Federazione Russa 100
VN - Vietnam 88
FR - Francia 53
CA - Canada 44
AR - Argentina 38
PL - Polonia 37
IN - India 34
MX - Messico 28
BE - Belgio 22
EC - Ecuador 21
AT - Austria 19
TR - Turchia 19
BD - Bangladesh 18
ES - Italia 16
NL - Olanda 15
ZA - Sudafrica 15
IR - Iran 14
JP - Giappone 11
MA - Marocco 11
PK - Pakistan 9
ID - Indonesia 8
IQ - Iraq 8
UZ - Uzbekistan 8
VE - Venezuela 8
CL - Cile 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 6
CZ - Repubblica Ceca 6
PE - Perù 6
TN - Tunisia 6
EG - Egitto 5
JO - Giordania 5
BO - Bolivia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
IL - Israele 3
KG - Kirghizistan 3
NO - Norvegia 3
RO - Romania 3
SY - Repubblica araba siriana 3
AL - Albania 2
BH - Bahrain 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
OM - Oman 2
PH - Filippine 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MN - Mongolia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.219
Salva come PNG Salva come JPEG
Città #
Dublin 622
Chandler 562
Jacksonville 450
Singapore 440
Ashburn 383
Dallas 362
Nyköping 298
Beijing 282
Hong Kong 270
Dearborn 122
Princeton 109
Cambridge 106
Medford 106
The Dalles 101
Messina 97
Ann Arbor 90
Des Moines 90
Los Angeles 89
Boardman 76
New York 72
São Paulo 65
Munich 62
Buffalo 51
Woodbridge 46
Warsaw 33
Ho Chi Minh City 30
Wilmington 29
Tianjin 27
Belo Horizonte 25
Moscow 25
Brussels 22
Lancaster 22
Redondo Beach 22
Hanoi 19
Turku 19
Shenyang 18
Vienna 18
San Mateo 16
Hebei 15
Jinan 15
London 15
Montreal 15
Nanjing 15
Rio de Janeiro 15
Porto Alegre 14
Brasília 12
Frankfurt am Main 12
Helsinki 12
Recife 12
Houston 11
Rome 11
Seattle 11
Tokyo 11
Bremen 10
Johannesburg 10
Palermo 10
Pune 10
Auburn Hills 9
Chennai 9
Düsseldorf 9
Poplar 9
Quito 9
Council Bluffs 8
Hangzhou 8
Milan 8
Ningbo 8
Stockholm 8
Tashkent 8
Washington 8
Fortaleza 7
Orem 7
Reggio Calabria 7
Ribeirão Preto 7
Salvador 7
San Francisco 7
Santa Clara 7
Strasbourg 7
Zhengzhou 7
Ardabil 6
Augusta 6
Bauru 6
Chicago 6
Curitiba 6
Dong Ket 6
Lanzhou 6
Lauterbourg 6
Mexico City 6
Nairobi 6
Ottawa 6
Phoenix 6
São José dos Campos 6
Atlanta 5
Betim 5
Boston 5
Campinas 5
Caratinga 5
Changsha 5
Denver 5
Falls Church 5
Guarulhos 5
Totale 5.799
Salva come PNG Salva come JPEG
Nome #
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 178
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 150
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 148
E rosette formation in B cell chronic lymphocytic leukemia. 145
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 145
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 135
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 133
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 132
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 130
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 130
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 128
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 124
The cancer stem cell hypothesis: a guide to potential molecular targets. 123
L'ipersplenismo: attualità e prospettive future 123
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 121
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 119
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 118
Beta 2 microglobulina ed emopatie maligne 117
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 115
Serum levels of interleukin-16 in lymphoid malignancies. 114
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 114
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 113
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 113
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 110
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 107
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 107
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 105
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 102
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 98
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 98
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 95
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 95
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 95
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 95
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 94
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 94
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 91
Standardisation of minimal residual disease in multiple myeloma 90
Cardiac involvement in patients with hematologic malignancies. 89
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 89
Lipid profile in hematologic neoplasms 88
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 88
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 86
Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. 86
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 86
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 85
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 84
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. 82
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 81
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 80
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. 79
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 77
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis 77
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 76
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 75
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 75
Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration 74
Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement 74
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. 74
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. 74
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 73
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 73
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia 72
EFFECTIVE THERAPY OF APLASTIC-ANEMIA POSTHEPATITIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN 71
Screening dei deficit di G-6-PD in un campione di una popolazione scolastica 71
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response 70
JAK2-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease. 69
Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone. 69
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 69
SERUM LEVELS OF CD8-ANTIGEN AND SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 68
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. 68
Epigenetic therapy in myelodysplastic syndromes. 68
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. 68
Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. 67
POLYRADICOLONEUROPATHY AS A FORM OF RELAPSE IN A PATIENT WITH ACUTE MEGACARYOCYTIC LEUKAEMIA 66
MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA 66
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options. 66
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 65
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 64
Soluble angiogenic factors: Implications for chronic myeloproliferative disorders 64
Evaluation of circulating endothelial progenitor cells in patients with bisphosphonate-associated osteonecrosis of the jaw 64
Prognostic significance of immunophenotype in chronic lymphocytic leukaemia 63
METHYMAZOLE-INDUCED AGRANULOCYTOSIS AND QUICK RECOVERY WITH G-CSF: CARE REPORT 63
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 63
Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1. 62
Serum levels of interleukin-16 in a multiple myeloma patient with cutaneous involvement. 62
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. 61
Significance of serum interleukin-16 levels in patients with B-cell chronic lymphocytic leukemia 60
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 60
Nanoparticles in oncology: the new theragnostic molecules. 60
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. 59
E-ROSETTE FORMATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 57
Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies. 57
Serum levels of Interleukin-16 as an important prognostic factor in multiple Myeloma patient with cutaneous involvement 56
Differential levels of soluble angiopèoietin-2 and Tie-2 in patients with haematological malignancies 56
Correlazione del polimorfismo genico di MDR-1 con i nuovi marcatori prognostici in pazienti affetti da Leucemia Linfatica Cronica a cellule B. 56
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease 56
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires 56
Differential levels of soluble endoglin (CD105) in myeloid malignancies 55
New orally active proteasome inhibitors in multiple myeloma. 54
Totale 8.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 92 8 41 41 85 81 59
2021/2022641 5 57 14 20 18 8 40 26 13 89 98 253
2022/20231.944 164 168 82 174 165 199 17 110 775 9 58 23
2023/2024448 39 73 28 35 49 118 20 30 3 11 6 36
2024/20252.166 23 27 49 170 79 43 8 532 580 114 189 352
2025/20261.970 259 396 368 422 473 52 0 0 0 0 0 0
Totale 9.274